Role of biomarkers of cardiac remodeling, myofibrosis, and inflammation in assessment of disease severity in euvolemic patients with chronic stable heart failure.
Táňa AndreasováJana VránováDagmar VondrákováLenka SedláčkováZuzana Jirásková ZákostelskáPetr NeužilFilip MálekPublished in: The Journal of international medical research (2021)
Besides NT-proBNP, GDF-15 and cystatin C are promising biomarkers for establishing the severity of disease in euvolemic patients with stable CHF.